Viewing Study NCT03603444



Ignite Creation Date: 2024-05-06 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 12:50 PM
Study NCT ID: NCT03603444
Status: COMPLETED
Last Update Posted: 2018-07-27
First Post: 2018-07-10

Brief Title: Reliability of Serum Calcium to Phosphorus CaP Ratio as an Accurate and Inexpensive Tool to Define Disorders of Ca-P Metabolism
Sponsor: Azienda Ospedaliero-Universitaria di Modena
Organization: Azienda Ospedaliero-Universitaria di Modena

Study Overview

Official Title: Serum Calcium to Phosphorus CaP Ratio to Define Disorders of Ca-P Metabolism
Status: COMPLETED
Status Verified Date: 2018-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: BACKGROUND Primary hyperparathyroidism PHPT is the third most common endocrine disorder The CaP ratio is an accurate tool to differentiate patients with PHPT 35 if Ca and P are expressed in mgdl from healthy subjects The reliability of this index is based on the fact that serum Ca and P are inversely related together However other disorders of the Ca-P metabolism such as hypophosphoremia HypoP not related to PHPT might also impair the CaP ratio

OBJECTIVE To validate the accuracy of CaP ratio in the diagnosis of Ca-P metabolism disorders including also patients with documented HypoP not related to PHPT

METHODS A single-center retrospective case-control study will be carried out

Biochemical measurements will include parathormone PTH vitamin D serum Ca and P serum albumin and creatinine
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None